Urispas: Targeted Relief for Bladder Spasms and Urinary Discomfort
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.28 (0%) | 🛒 Add to cart |
| 60 | $1.12 | $82.56 $67.08 (19%) | 🛒 Add to cart |
| 90 | $1.04 | $123.84 $93.74 (24%) | 🛒 Add to cart |
| 120 | $1.00 | $165.12 $119.54 (28%) | 🛒 Add to cart |
| 180 | $0.96 | $247.68 $172.86 (30%) | 🛒 Add to cart |
| 270 | $0.94 | $371.52 $252.84 (32%) | 🛒 Add to cart |
| 360 | $0.92
Best per pill | $495.36 $331.10 (33%) | 🛒 Add to cart |
Synonyms | |||
Urispas (generic name: flavoxate hydrochloride) is an antispasmodic medication specifically formulated to target and relieve symptoms associated with urinary tract dysfunction. It works by relaxing the smooth muscle of the urinary bladder, thereby reducing frequency, urgency, and incontinence linked to conditions such as cystitis, prostatitis, urethritis, and other lower urinary tract irritations. By directly addressing the underlying muscular hyperactivity, Urispas provides symptomatic relief, improving comfort and daily functioning for patients experiencing disruptive bladder-related symptoms. This medication is typically prescribed as part of a broader management plan and should be used under appropriate medical supervision.
Features
- Active ingredient: Flavoxate hydrochloride
- Available in 200 mg tablet formulation
- Anticholinergic and direct smooth muscle relaxant properties
- Specifically targets urinary tract smooth muscle
- Oral administration with systemic absorption
- Prescription-only medication
Benefits
- Reduces urinary urgency and frequency, allowing for better bladder control
- Alleviates painful or uncomfortable bladder spasms
- Decreases episodes of urge incontinence
- Improves overall quality of life by minimizing sleep disruptions due to nocturia
- Supports comprehensive urological treatment plans
- Enables greater daily activity and comfort
Common use
Urispas is commonly prescribed for the symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency, and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis, or urethrotrigonitis. It is particularly useful in managing overactive bladder (OAB) symptoms and is often recommended alongside other treatments such as antibiotics in cases of infection or behavioral therapies for long-term management. It is not intended to treat the underlying cause of infection but rather to alleviate the uncomfortable muscular symptoms accompanying these conditions.
Dosage and direction
The typical adult dosage is one 200 mg tablet three or four times daily. Dosage may be adjusted based on individual response and tolerance. Tablets should be swallowed whole with a full glass of water, with or without food. It is important to follow the prescribing physician’s instructions precisely and not to exceed the recommended dosage. Treatment duration varies depending on the condition being managed and patient response; long-term use should be reevaluated periodically by a healthcare provider.
Precautions
Patients should inform their healthcare provider of any history of glaucoma, gastrointestinal obstruction, urinary retention, or hepatic or renal impairment. Use with caution in elderly patients due to increased susceptibility to anticholinergic effects. This medication may cause drowsiness or blurred vision; patients should avoid driving or operating machinery until they know how Urispas affects them. Alcohol and other CNS depressants may enhance drowsiness. Not recommended for use during pregnancy or lactation unless clearly needed and under medical supervision.
Contraindications
Urispas is contraindicated in patients with known hypersensitivity to flavoxate hydrochloride or any component of the formulation. It should not be used in individuals with gastrointestinal obstruction, paralytic ileus, significant urinary retention, uncontrolled narrow-angle glaucoma, or severe ulcerative colitis. It is also contraindicated in patients with myasthenia gravis or obstructive uropathy.
Possible side effects
Common side effects may include dry mouth, drowsiness, blurred vision, nausea, vomiting, and dizziness. Less frequently, patients may experience nervousness, headache, confusion (especially in elderly patients), tachycardia, palpitations, increased intraocular pressure, or skin rash. Serious side effects such as difficulty urinating or severe abdominal pain should be reported immediately to a healthcare provider.
Drug interaction
Urispas may interact with other anticholinergic agents, potentially increasing side effects. Concurrent use with CNS depressants (e.g., benzodiazepines, opioids, alcohol) may enhance sedative effects. It may also interfere with the absorption of other orally administered drugs due to reduced gastrointestinal motility. Caution is advised when using with monoamine oxidase inhibitors (MAOIs) or other drugs that affect cholinergic transmission.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose may include severe drowsiness, dizziness, dry mouth, blurred vision, urinary retention, tachycardia, and respiratory depression. In case of suspected overdose, seek immediate medical attention or contact a poison control center. Treatment is symptomatic and supportive; there is no specific antidote.
Storage
Store at room temperature (15–30°C or 59–86°F), away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is provided for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized medical guidance. Do not initiate, discontinue, or change dosage without medical supervision.
Reviews
Clinical studies and patient reports indicate that Urispas is effective in reducing urinary urgency and discomfort associated with various urological conditions. Many users report significant improvement in symptom frequency and quality of life. However, individual responses may vary, and some patients experience side effects such as dry mouth or drowsiness. It is generally regarded as a useful adjunct in managing bladder spasm-related symptoms when used appropriately under medical guidance.